SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Omkar Pharmachem - Quaterly Results

14 Feb 2024 Evaluate
Revenue showed a marginal decline at Rs. 1.35 millions. For the quarter ended December 2023, as compared to corresponding quarter of last year.A slender decline of -20.24% was recorded to Rs. 0.67  millions from Rs. 0.84 millions in the corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 0.68 millions from 0.85 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1.35 1.35 0.00 4.05 4.05 0.00 5.40 5.40 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00
PBIDT 0.68 0.85 -20.00 2.09 2.08 0.48 3.13 2.68 16.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.46 0.56 -17.86
PBDT 0.68 0.85 -20.00 2.09 2.08 0.48 2.67 2.12 25.94
Depreciation 0.01 0.01 0.00 0.03 0.03 0.00 0.03 0.02 50.00
PBT 0.67 0.84 -20.24 2.06 2.05 0.49 2.64 2.10 25.71
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.67 0.27 148.15
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.67 0.84 -20.24 2.06 2.05 0.49 1.97 1.83 7.65
Equity 100.84 100.84 0.00 100.84 100.84 0.00 100.84 100.84 0.00
PBIDTM(%) 50.37 62.96 -20.00 51.60 51.36 0.48 57.96 49.63 16.79

Omkar Pharmachem Share Price

20.21 -1.06 (-4.98%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 454.70
Indegene 518.55
CMS Info Systems 291.00
JITF Infralogistics 296.40
Sagility 40.13
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×